Incontinentia pigmenti diagnostic criteria update

Clinical Genetics

Volumn 85, Issue 6, 2014, Pages 536-542

  Minic S ^a   Trpinac, D ^b   Obradovic M ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Anomalies; Diagnostic criteria; IKBKG gene; Incontinentia pigmenti; Molecular genetic testing

Indexed keywords

ARTICLE; DIFFERENTIAL DIAGNOSIS; EYE DISEASE; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC SCREENING; HAIR DISEASE; HISTOPATHOLOGY; HUMAN; IKBKG GENE; INCONTINENTIA PIGMENTI; META ANALYSIS (TOPIC); MOUTH DISEASE; NAIL DISEASE; NIPPLE MALFORMATION; PHENOTYPE; PRIORITY JOURNAL; SKIN MANIFESTATION; SPONTANEOUS ABORTION; TOOTH DISEASE; FEMALE; GENE LOCUS; GENETICS; MALE; META ANALYSIS; MUTATION; PATHOLOGY; SEX DIFFERENCE; X CHROMOSOME;

I KAPPA B KINASE; IKBKG PROTEIN, HUMAN;

CHROMOSOMES, HUMAN, X; FEMALE; GENETIC LOCI; HUMANS; I-KAPPA B KINASE; INCONTINENTIA PIGMENTI; MALE; MUTATION; SEX FACTORS;

EID: 84899481614     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12223     Document Type: Article

References (44)

1. Orphanet Report Series. Prevalence of rare diseases: Bibliographic data. 2012, from http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdf. Accessed February 20, 2013.
2. Scheuerle A, Ursini MV. Incontinentia pigmenti (Bloch-Sulzberger syndrome). University of Washington, Seattle (WA): GeneReviews 2008, from http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=i-p. Accessed February 20 2013.
3. Landy SJ, Donnai D. Incontinentia pigmenti (Bloch-Sulzberger syndrome). J Med Genet 1993: 30: 53-59. DOI: 10.1136/jmg.30.1.53.
4. Minić S, Trpinac D, Obradović M. Central nervous system anomalies in incontinentia pigmenti. Orphanet J Rare Dis 2013: 8: 25. DOI: 10.1186/1750-1172-8-25.
5. Smahi A, Courtois G, Vabres P et al. Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 2000: 405: 466-472. DOI: 10.1038/35013114.
6. Kaufman CK, Fuchs E. It's got you covered: NF-κB in the epidermis. J Cell Biol 2000: 149: 999-1004. DOI: 10.1083/jcb.149.5.999.
7. Minić S, Trpinac D, Gabriel H, Gencik M, Obradović M. Dental and oral anomalies in incontinentia pigmenti: a systematic review. Clin Oral Invest 2013: 17: 1-8. DOI: 10.1007/s00784-012-0721-5.
8. Fusco F, Pescatore A, Steffan J, Royer G, Bonnefont JP, Ursini MV. Clinical utility gene card for: incontinentia pigmenti. Eur J Hum Genet 2013: 21. DOI: 10.1038/ejhg.2012.227.
9. Minić S, Novotny GEK, Trpinac D, Obradović M. Clinical features of incontinentia pigmenti with emphasis on oral and dental abnormalities. Clin Oral Invest 2006: 10: 343-347. DOI: 10.1007/s00784-006-0066-z.
10. Hadj-Rabia S, Rimella A, Smahi A et al. Clinical and histologic features of incontinentia pigmenti in adults with nuclear factor-κB essential modulator gene mutations. J Am Acad Dermatol 2011: 64: 508-515. DOI: 10.1016/j.jaad.2010.01.045.
11. Donnai D. Incontinentia Pigmenti. In: Cassidy S, Allanson JE, eds. Management of genetic syndromes, 2nd edn. Hoboken, NJ: Wiley-Liss, 2005: 309-314.
12. Hadj-Rabia S, Froidevaux D, Bodak N et al. Clinical study of 40 cases of incontinentia pigmenti. Arch Dermatol 2003: 139: 1163-1170. DOI: 10.1001/archderm.139.9.1163.
13. Fraitag S, Rimella A, de Prost Y, Brousse N, Hadj-Rabia S, Bodemer C. Skin biopsy is helpful for the diagnosis of incontinentia pigmenti at late stage (IV): a series of 26 cutaneous biopsies. J Cutan Pathol 2009: 36: 966-971. DOI: 10.1111/j.1600-0560.2009.01206.x.
14. Berlin AL, Paller AS, Chan LS. Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology. J Am Acad Dermatol 2002: 47: 169-187. DOI: 10.1067/mjd.2002.125949.
15. Chen H. Atlas of genetic diagnosis and counseling. Totowa, NJ: Humana Press Inc, 2006: 539-544.
16. Badgwell AL, Iglesias AD, Emmerich S, Willner JP. The natural history of incontinentia pigmenti as reported by 198 affected individuals. Abstract 38. American College of Medical Genetics Annual Meeting: Nashville, TN, 2007.
17. Chun BS, Rashid R. Delayed onychodystrophy of incontinentia pigmenti: an evidence-based review of epidemiology, diagnosis and management. J Drugs Dermatol 2010: 9: 350-354.
18. Carney RG. Incontinentia pigmenti: a world statistical analysis. Arch Dermatol 1976: 112: 535-542. DOI: 10.1001/archderm.1976.01630280059017.
19. Boyd E, Stevenson RE. Breasts. In: Stevenson RE, Hall JG, eds. Human malformations and related anomalies, 2nd edn. New York, NY: Oxford University Press, 2006: 1049-1064.
20. Fusco F, Bardaro T, Fimiani G et al. Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-κB activation. Hum Mol Genet 2004: 13: 1763-1773. DOI: 10.1093/hmg/ddh192.
21. Phan TA, Wargon O, Turner AM. Incontinentia pigmenti case series: clinical spectrum of incontinentia pigmenti in 53 female patients and their relatives. Clin Exp Dermatol 2005: 30: 474-480. DOI: 10.1111/j.1365-2230.2005.01848.x.
22. Holmström G, Bergendal B, Hallberg G, Marcus S, Hallén A, Dahl N. Incontinentia pigmenti-a rare disease with many symptoms. Lakartidningen 2002: 99: 1345-1350.
23. Goldberg MF. The skin is not the predominant problem in incontinentia pigmenti. Arch Dermatol 2004: 140: 748-750. DOI: 10.1001/archderm.140.6.748.
24. Holmström G, Thorén K. Ocular manifestations of incontinentia pigmenti. Acta Ophthalmol Scand 2000: 78: 348-353. DOI: 10.1034/j.1600-0420.2000.078003348.x.
25. Kim BJ, Shin HS, Won CH et al. Incontinentia pigmenti: clinical observation of 40 Korean cases. J Korean Med Sci 2006: 21: 474-477. DOI: 10.3346/jkms.2006.21.3.474.
26. Pascual-Castroviejo I, Pascual-Pascual SI, Velázquez-Fragua R, Martinez V. Incontinentia pigmenti: clinical and neuroimaging findings in a series of 12 patients. Neurologia 2006: 21: 239-248.
27. Minić S, Obradović M, Kovačević I, Trpinac D. Ocular anomalies in incontinentia pigmenti-literature review and meta-analysis. Srp Arh Celok Lek 2010: 138: 408-413. DOI: 10.2298/SARH1008408M.
28. Equi R, Bains HS, Jampol LM, Goldberg MF. Retinal tears occurring at the border of vascular and avascular retina in adult patients with incontinentia pigmenti. Retina 2003: 23: 574-576.
29. Fekrat S, Humayun MS, Goldberg MF. Spontaneous retinal reattachment in incontinentia pigmenti. Retina 1998: 18: 75-77.
30. Goldberg MF, Custis PH. Retinal and other manifestations of incontinentia pigmenti (Bloch-Sulzberger syndrome). Ophthalmology 1993: 100: 1645-1654. DOI: 10.1016/S0161-6420(93)31422-3.
31. Yee KT. The Special Senses. In: Keeling JS, Yee Khong T, eds. Fetal and neonatal pathology, 4th edn. London: Springer-Verlag, 2007: 825-850.
32. Centers for Disease Control and Prevention (CDC). Improved national prevalence estimates for 18 selected major birth defects-United States, 1999-2001. MMWR Morb Mortal Wkly Rep 2006: 54: 1301-1305.
33. Traboulsi EI. Eye. In: Stevenson RE, Hall JG, eds. Human malformations and related anomalies, 2nd edn. New York: Oxford University Press, 2006: 297-325.
34. Ropers HH, Hamel BC. X-linked mental retardation. Nat Rev Genet 2005: 6: 46-57. DOI: 10.1038/nrg1501.
35. EUROCAT Prevalence Data Tables, 2013 from http://www.eurocat-network.eu/prevdata/resultsPdf.aspx?title=B3&allanom=false&allregf=true&allrega=true&anomalies=8&winx=1256&winy=894. Accessed on February 20, 2013.
36. Theodore WH, Spencer SS, Wiebe S et al. Epilepsy in North America: a report prepared under the auspices of the global campaign against epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization. Epilepsia 2006: 47: 1700-1722. DOI: 10.1111/j.1528-1167.2006.00633.x.
37. Galasso C, Lo-Castro A, El-Malhany N, Curatolo P. "Idiopathic" mental retardation and new chromosomal abnormalities. Ital J Pediatr 2010: 36: 17. DOI: 10.1186/1824-7288-36-17.
38. Jean-Baptiste S, O'Toole EA, Chen M, Guitart J, Paller A, Chan LS. Expression of eotaxin, an eosinophil-selective chemokine, parallels eosinophil accumulation in the vesiculobullous stage of incontinentia pigmenti. Clin Exp Immunol 2002: 127: 470-478. DOI: 10.1046/j.1365-2249.2002.01755.x.
39. Minić S, Trpinac D, Obradović M, Novotny GE, Gabriel HD, Kuhn M. Incontinentia pigmenti with ultrastructurally disordered leucocytes. J Clin Pathol 2010: 63: 657-659. DOI: 10.1136/jcp.2009.074203.
40. Fusco F, Paciolla M, Napolitano F et al. Genomic architecture at the Incontinentia Pigmenti locus favours de novo pathological alleles through different mechanisms. Hum Mol Genet 2012: 21: 1260-1271. DOI: 10.1093/hmg/ddr556.
41. Kenwrick S, Woffendin H, Jakins T et al. Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome. Am J Hum Genet 2001: 69: 1210-1217. DOI: 10.1086/324591.
42. Gregersen PA, Sommerlund M, Ramsing M, Gjørup H, Rasmussen AA, Aggerholm A. Diagnostic and molecular genetic challenges in male incontinentia pigmenti: a case report. Acta Derm Venereol 2013. DOI: 10.2340/00015555-1593.
43. Fusco F, Pescatore A, Bal E et al. Alterations of the IKBKG locus and diseases: an update and a report of 13 novel mutations. Hum Mutat 2008: 29: 595-604. [Epub ahead of print]. DOI: 10.1002/humu.20739.
44. Parrish JE, Scheuerle AE, Lewis RA, Levy ML, Nelson DL. Selection against mutant alleles in blood leukocytes is a consistent feature in incontinentia pigmenti type 2. Hum Mol Genet 1996: 5: 1777-1783. DOI: 10.1093/hmg/5.11.1777.